Scandinavian Journal of Rheumatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research